RxNorm Semantic Concepts Index - 239
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "239".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 239 | Aclarubicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 239 | Aclarubicin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 239 | Aclarubicin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 239 | Aclarubicin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 239 | Aclarubicin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390033 | Isavuconazole (as isavuconazonium sulfate) 200 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390033 | Isavuconazole (as isavuconazonium sulfate) 200 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390035 | Antigen of Wuchereria bancrofti | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390035 | Antigen of Wuchereria bancrofti | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390035 | Antigen of Wuchereria bancrofti | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390035 | Antigen of Wuchereria bancrofti | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390038 | Antigen of inactivated whole Human poliovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390038 | Antigen of inactivated whole Human poliovirus | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390038 | Antigen of inactivated whole Human poliovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390038 | Antigen of inactivated whole Human poliovirus | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390041 | Antigen of inactivated whole Rabies lyssavirus grown in brain tissue | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390041 | Antigen of inactivated whole Rabies lyssavirus grown in brain tissue | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390041 | Antigen of inactivated whole Rabies lyssavirus grown in brain tissue | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390041 | Antigen of inactivated whole Rabies lyssavirus grown in brain tissue | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390041 | Antigen of inactivated whole Rabies lyssavirus grown in brain tissue | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390042 | Antigen of inactivated whole Rabies lyssavirus grown in cellular line | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390042 | Antigen of inactivated whole Rabies lyssavirus grown in cellular line | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390042 | Antigen of inactivated whole Rabies lyssavirus grown in cellular line | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390042 | Antigen of inactivated whole Rabies lyssavirus grown in cellular line | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390042 | Antigen of inactivated whole Rabies lyssavirus grown in cellular line | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390044 | Antigen of inactivated whole Human alphaherpesvirus 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390044 | Antigen of inactivated whole Human alphaherpesvirus 3 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390044 | Antigen of inactivated whole Human alphaherpesvirus 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390044 | Antigen of inactivated whole Human alphaherpesvirus 3 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390044 | Antigen of inactivated whole Human alphaherpesvirus 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390045 | Antigen of inactivated whole Rabies lyssavirus WISTAR PM/W1 38 1503-3M strain grown in cellular line | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390045 | Antigen of inactivated whole Rabies lyssavirus WISTAR PM/W1 38 1503-3M strain grown in cellular line | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390045 | Antigen of inactivated whole Rabies lyssavirus WISTAR PM/W1 38 1503-3M strain grown in cellular line | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390045 | Antigen of inactivated whole Rabies lyssavirus WISTAR PM/W1 38 1503-3M strain grown in cellular line | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390045 | Antigen of inactivated whole Rabies lyssavirus WISTAR PM/W1 38 1503-3M strain grown in cellular line | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390049 | Orexin receptor antagonist-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390049 | Orexin receptor antagonist-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390050 | Growth hormone receptor antagonist | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390050 | Growth hormone receptor antagonist | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390050 | Growth hormone receptor antagonist | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390050 | Growth hormone receptor antagonist | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 239009 | benzocaine 20 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 239009 | benzocaine 20 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239009 | benzocaine 20 % Otic Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 239009 | benzocaine 20 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239009 | benzocaine 20 % Otic Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 239018 | ammonium chloride 100 MEQ in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239018 | ammonium chloride 100 MEQ in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239018 | ammonium chloride 100 MEQ in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 239018 | ammonium chloride 100 MEQ in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390278 | Midazolam-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390278 | Midazolam-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390280 | Naloxone-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390280 | Naloxone-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390281 | Product containing sufentanil in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390281 | Product containing sufentanil in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390282 | Product containing tetracaine in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390282 | Product containing tetracaine in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390283 | Product containing sulfadiazine in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390283 | Product containing sulfadiazine in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390284 | Anethum graveolens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2390285 | Malus domestica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2390291 | doxylamine succinate 3.26 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2390292 | doxylamine succinate 9.78 MG in 3 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390292 | doxylamine succinate 9.78 MG in 3 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2390292 | doxylamine succinate 9.78 MG in 3 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390296 | povidone-iodine 2.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390296 | povidone-iodine 2.5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2390296 | povidone-iodine 2.5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390302 | Cellulose and/or cellulose derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390302 | Cellulose and/or cellulose derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390303 | Product containing psyllium and/or psyllium derivative (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390303 | Product containing psyllium and/or psyllium derivative (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390305 | Amikacin liposome-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390305 | Amikacin liposome-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390308 | Carrier oil-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390308 | Carrier oil-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390309 | Equine diphtheria antitoxin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390309 | Equine diphtheria antitoxin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390312 | Fluorodopa (18-F)-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390312 | Fluorodopa (18-F)-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390314 | Lisinopril dihydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390314 | Lisinopril dihydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390315 | Fluoropyrimidine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390315 | Fluoropyrimidine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390316 | Antigen of Neisseria meningitidis serogroup C capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390316 | Antigen of Neisseria meningitidis serogroup C capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390316 | Antigen of Neisseria meningitidis serogroup C capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390316 | Antigen of Neisseria meningitidis serogroup C capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390317 | Antigen of Neisseria meningitidis serogroup CW135 capsular oligosaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390317 | Antigen of Neisseria meningitidis serogroup CW135 capsular oligosaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390317 | Antigen of Neisseria meningitidis serogroup CW135 capsular oligosaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390317 | Antigen of Neisseria meningitidis serogroup CW135 capsular oligosaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390318 | Antigen of Neisseria meningitidis serogroup CW135 capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390318 | Antigen of Neisseria meningitidis serogroup CW135 capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390318 | Antigen of Neisseria meningitidis serogroup CW135 capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390318 | Antigen of Neisseria meningitidis serogroup CW135 capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390319 | Fibric acid and/or fibric acid derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390319 | Fibric acid and/or fibric acid derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390321 | Antigen of Neisseria meningitidis serogroup A capsular oligosaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390321 | Antigen of Neisseria meningitidis serogroup A capsular oligosaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390321 | Antigen of Neisseria meningitidis serogroup A capsular oligosaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390321 | Antigen of Neisseria meningitidis serogroup A capsular oligosaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390322 | Antigen of Neisseria meningitidis serogroup A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390322 | Antigen of Neisseria meningitidis serogroup A capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390322 | Antigen of Neisseria meningitidis serogroup A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390322 | Antigen of Neisseria meningitidis serogroup A capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390323 | Antigen of Neisseria meningitidis serogroup Y capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390323 | Antigen of Neisseria meningitidis serogroup Y capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390323 | Antigen of Neisseria meningitidis serogroup Y capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390323 | Antigen of Neisseria meningitidis serogroup Y capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390324 | Antigen of Neisseria meningitidis serogroup Y capsular oligosaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390324 | Antigen of Neisseria meningitidis serogroup Y capsular oligosaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390324 | Antigen of Neisseria meningitidis serogroup Y capsular oligosaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390324 | Antigen of Neisseria meningitidis serogroup Y capsular oligosaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390325 | Immunoglobulin G antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390325 | Immunoglobulin G antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390325 | Immunoglobulin G antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390325 | Immunoglobulin G antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390325 | Immunoglobulin G antibody to 2019 novel coronavirus | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390325 | Immunoglobulin G antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390325 | Immunoglobulin G antibody to 2019 novel coronavirus | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390326 | Immunoglobulin M antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390326 | Immunoglobulin M antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390326 | Immunoglobulin M antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390326 | Immunoglobulin M antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390326 | Immunoglobulin M antibody to 2019 novel coronavirus | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390326 | Immunoglobulin M antibody to 2019 novel coronavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390326 | Immunoglobulin M antibody to 2019 novel coronavirus | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390327 | Antigen of Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390327 | Antigen of Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi unconjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390327 | Antigen of Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390327 | Antigen of Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi unconjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390327 | Antigen of Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390327 | Antigen of Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390328 | Nematode antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390328 | Nematode antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390329 | Trematode antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390329 | Trematode antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390330 | Antigen of Dirofilaria immitis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390330 | Antigen of Dirofilaria immitis | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390330 | Antigen of Dirofilaria immitis | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390330 | Antigen of Dirofilaria immitis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390331 | Afamelanotide-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390331 | Afamelanotide-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390332 | Mesna-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390332 | Mesna-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390333 | Mycophenolic acid-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390333 | Mycophenolic acid-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390334 | Ondansetron hydrochloride dihydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390334 | Ondansetron hydrochloride dihydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390335 | Minocycline hydrochloride dihydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390335 | Minocycline hydrochloride dihydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390336 | Antigen of Neisseria meningitidis serogroup C capsular oligosaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390336 | Antigen of Neisseria meningitidis serogroup C capsular oligosaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390336 | Antigen of Neisseria meningitidis serogroup C capsular oligosaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390336 | Antigen of Neisseria meningitidis serogroup C capsular oligosaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390337 | Antigen of live attenuated Human poliovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390337 | Antigen of live attenuated Human poliovirus | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390337 | Antigen of live attenuated Human poliovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390337 | Antigen of live attenuated Human poliovirus | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390338 | Antigen of live attenuated Human poliovirus serotype 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390338 | Antigen of live attenuated Human poliovirus serotype 2 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390338 | Antigen of live attenuated Human poliovirus serotype 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390338 | Antigen of live attenuated Human poliovirus serotype 2 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390339 | Antigen of Echinococcus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390339 | Antigen of Echinococcus | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390339 | Antigen of Echinococcus | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390339 | Antigen of Echinococcus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390340 | Antigen of Clostridium tetani toxoid adsorbed | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390340 | Antigen of Clostridium tetani toxoid adsorbed | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390340 | Antigen of Clostridium tetani toxoid adsorbed | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390340 | Antigen of Clostridium tetani toxoid adsorbed | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390340 | Antigen of Clostridium tetani toxoid adsorbed | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390341 | Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390341 | Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390341 | Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390341 | Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390342 | Fluorodopa (18-F)-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390342 | Fluorodopa (18-F)-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390354 | benzalkonium chloride 12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2390355 | benzalkonium chloride 1.2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2390355 | benzalkonium chloride 1.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390355 | benzalkonium chloride 1.2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390356 | benzalkonium chloride 3.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2390357 | benzalkonium chloride 0.38 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2390357 | benzalkonium chloride 0.38 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390357 | benzalkonium chloride 0.38 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390358 | ethanol 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2390359 | benzalkonium chloride 0.1 % / ethanol 60 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2390359 | benzalkonium chloride 0.1 % / ethanol 60 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390359 | benzalkonium chloride 0.1 % / ethanol 60 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390363 | Haemoglobin S polymerization inhibitor-containing product | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2390363 | Haemoglobin S polymerization inhibitor-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2390363 | Haemoglobin S polymerization inhibitor-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2390439 | phenylpropanolamine hydrochloride 9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2390445 | phenylpropanolamine hydrochloride 25 MG [Propagest] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2390450 | phenylpropanolamine hydrochloride 37.5 MG [Westrim] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2390459 | phenylpropanolamine hydrochloride 75 MG [Empro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2390463 | phenylpropanolamine hydrochloride 75 MG [Propan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2390465 | phenylpropanolamine hydrochloride 75 MG [Rhindecon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2390468 | phenylpropanolamine hydrochloride 75 MG [Westrim LA] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2390509 | clemastine fumarate 1.34 MG / phenylpropanolamine hydrochloride 75 MG [Allerhist-D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2390514 | clemastine fumarate 1.34 MG / phenylpropanolamine hydrochloride 75 MG [Dayhist-D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2390517 | clemastine fumarate 1.34 MG / phenylpropanolamine hydrochloride 75 MG [Tavist-D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 239053 | colchicine / probenecid Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 239056 | tubocurarine 3 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390629 | triceteth-4 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2390630 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2390630 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2390630 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390630 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390630 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2390643 | enzalutamide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2390644 | enzalutamide 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390644 | enzalutamide 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2390645 | enzalutamide Oral Tablet [Xtandi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2390646 | Xtandi 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2390646 | Xtandi 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390646 | Xtandi 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390647 | enzalutamide 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2390648 | enzalutamide 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390648 | enzalutamide 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2390649 | enzalutamide 80 MG [Xtandi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2390650 | Xtandi 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2390650 | Xtandi 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390650 | Xtandi 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390757 | Magnolia sprengeri flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2390758 | Artemisia capillaris leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2390759 | Vitex rotundifolia fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2390760 | butidrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2390762 | Cicada periostracum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2390767 | {2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390767 | {2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2390768 | SUPREP PEDIATRIC BOWEL PREP KIT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390768 | SUPREP PEDIATRIC BOWEL PREP KIT | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2390768 | SUPREP PEDIATRIC BOWEL PREP KIT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390768 | SUPREP PEDIATRIC BOWEL PREP KIT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390776 | ethanol 0.753 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2390777 | ethanol 75.3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390777 | ethanol 75.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2390777 | ethanol 75.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239087 | petrolatum 10 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390935 | Product containing risdiplam (medicinal product) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2390935 | Product containing risdiplam (medicinal product) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2390935 | Product containing risdiplam (medicinal product) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2390935 | Product containing risdiplam (medicinal product) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2390935 | Product containing risdiplam (medicinal product) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2390940 | risdiplam 0.75 MG/mL Oral Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2390940 | risdiplam 0.75 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390940 | risdiplam 0.75 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390940 | risdiplam 0.75 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2390940 | risdiplam 0.75 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390940 | risdiplam 0.75 MG/mL Oral Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2390941 | Evrysdi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2390944 | Evrysdi Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2390945 | Evrysdi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2390946 | Evrysdi 0.75 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390946 | Evrysdi 0.75 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390946 | Evrysdi 0.75 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390946 | Evrysdi 0.75 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2390947 | ofatumumab 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2390948 | ofatumumab Pen Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2390949 | ofatumumab 20 MG in 0.4 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2390949 | ofatumumab 20 MG in 0.4 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390949 | ofatumumab 20 MG in 0.4 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390950 | Kesimpta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2390951 | ofatumumab 50 MG/ML [Kesimpta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2390952 | ofatumumab Pen Injector [Kesimpta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2390953 | Kesimpta Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2390954 | KESIMPTA 20 MG in 0.4 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390954 | KESIMPTA 20 MG in 0.4 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2390954 | KESIMPTA 20 MG in 0.4 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2390954 | KESIMPTA 20 MG in 0.4 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2390955 | ofatumumab 50 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2390956 | ofatumumab 50 MG/ML Pen Injector [Kesimpta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2390956 | ofatumumab 50 MG/ML Pen Injector [Kesimpta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2390961 | aculyn excel (polymer dispersion) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391134 | (3-bromopropyl)benzene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391135 | 1,3-benzenedisulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391136 | 3-(nonyloxy)1,2-propanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391137 | Adansonia digitata fruit pulp extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391139 | dibutyltin oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391140 | diphenyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2391141 | feclobuzone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391143 | C.I. direct red 28 parent | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391144 | cobalt titanium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391150 | triethanolamine tristearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391153 | salicylic acid 0.75 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391153 | salicylic acid 0.75 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391153 | salicylic acid 0.75 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391324 | bacitracin 0.5 UNT/MG [Baciguent] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2391325 | bacitracin Ophthalmic Ointment [Baciguent] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2391326 | Baciguent Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2391327 | Baciguent 500 UNT in GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391327 | Baciguent 500 UNT in GM Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391327 | Baciguent 500 UNT in GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391327 | Baciguent 500 UNT in GM Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2391332 | menthol 1.4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391332 | menthol 1.4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391332 | menthol 1.4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391333 | camphor 10 % / menthol 12 % / methyl salicylate 15 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391333 | camphor 10 % / menthol 12 % / methyl salicylate 15 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391333 | camphor 10 % / menthol 12 % / methyl salicylate 15 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391334 | dexbrompheniramine maleate 2 MG / phenylephrine HCl 7.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391334 | dexbrompheniramine maleate 2 MG / phenylephrine HCl 7.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391334 | dexbrompheniramine maleate 2 MG / phenylephrine HCl 7.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239151 | gelatin 600 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 239151 | gelatin 600 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391535 | Aloysia citrodora flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391536 | Syzygium aromaticum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 239154 | gelatin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2391541 | satralizumab | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2391541 | satralizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2391541 | satralizumab | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2391541 | satralizumab | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2391541 | satralizumab | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2391542 | Revolt | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2391543 | selamectin 120 MG/ML [Revolt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391544 | selamectin Topical Solution [Revolt] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391545 | Revolt Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2391546 | Revolt 120 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391546 | Revolt 120 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391546 | Revolt 120 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391547 | selamectin 60 MG/ML [Revolt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391548 | Revolt 60 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391548 | Revolt 60 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391548 | Revolt 60 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391549 | decyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391550 | cocotrimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2391551 | satralizumab-mwge | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2391552 | satralizumab-mwge 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2391553 | satralizumab Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2391553 | satralizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2391553 | satralizumab Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2391554 | satralizumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2391555 | satralizumab-mwge 120 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2391555 | satralizumab-mwge 120 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391555 | satralizumab-mwge 120 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391556 | Enspryng | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2391557 | satralizumab-mwge 120 MG/ML [Enspryng] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2391558 | satralizumab Prefilled Syringe [Enspryng] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2391559 | Enspryng Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2391560 | Enspryng 120 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391560 | Enspryng 120 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2391560 | Enspryng 120 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391560 | Enspryng 120 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391561 | satralizumab-mwge 120 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391562 | satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391562 | satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391564 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391564 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391564 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2391564 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391564 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391564 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2391565 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG [Novagesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391566 | Novagesic 500 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391566 | Novagesic 500 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391566 | Novagesic 500 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391566 | Novagesic 500 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391567 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG [Dologesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391568 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Dologesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391568 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Dologesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391568 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Dologesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391569 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391569 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2391569 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391570 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Vitoxapap] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391571 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Vitoxapap] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391571 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Vitoxapap] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391571 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Vitoxapap] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391572 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Uni-Perr] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391573 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Uni-Perr] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391573 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Uni-Perr] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391573 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Uni-Perr] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391574 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Q-Gesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391575 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Q-Gesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391575 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Q-Gesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391575 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Q-Gesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391576 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Phenylgesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391577 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Phenylgesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391577 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Phenylgesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391577 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Phenylgesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391578 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Phenagesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391579 | Dologesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391579 | Dologesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391579 | Dologesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391579 | Dologesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391581 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Perisine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391582 | Perisine 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391582 | Perisine 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391582 | Perisine 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391582 | Perisine 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391583 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Percogesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391584 | Percogesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391584 | Percogesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391584 | Percogesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391584 | Percogesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391585 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Pain-Gesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391586 | Pain-Gesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391586 | Pain-Gesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391586 | Pain-Gesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391586 | Pain-Gesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391587 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Major-gesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391588 | Major-gesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391588 | Major-gesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391588 | Major-gesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391588 | Major-gesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391589 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Genasec] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391590 | Genasec 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391590 | Genasec 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391590 | Genasec 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391590 | Genasec 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391591 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Duogesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391592 | Duogesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391592 | Duogesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391592 | Duogesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391592 | Duogesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391593 | Dolorex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2391594 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Dolorex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391595 | acetaminophen / phenyltoloxamine Oral Tablet [Dolorex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391596 | Dolorex Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2391597 | Dolorex Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2391598 | Dolorex 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391598 | Dolorex 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391598 | Dolorex 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391598 | Dolorex 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391603 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Apapgesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391604 | Apapgesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391604 | Apapgesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391604 | Apapgesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391604 | Apapgesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391605 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Apagesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391606 | Apagesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391606 | Apagesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391606 | Apagesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391606 | Apagesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391607 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Aceta-Gesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2391608 | Aceta-Gesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391608 | Aceta-Gesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391608 | Aceta-Gesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2391608 | Aceta-Gesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391609 | acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Contragesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2391610 | Contragesic 325 MG / 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2391610 | Contragesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391610 | Contragesic 325 MG / 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391610 | Contragesic 325 MG / 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391613 | acetaminophen 200 MG / aspirin 230 MG / phenylpropanolamine HCl 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391613 | acetaminophen 200 MG / aspirin 230 MG / phenylpropanolamine HCl 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391613 | acetaminophen 200 MG / aspirin 230 MG / phenylpropanolamine HCl 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391613 | acetaminophen 200 MG / aspirin 230 MG / phenylpropanolamine HCl 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391614 | acetaminophen 325 MG / phenyltoloxamine HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391614 | acetaminophen 325 MG / phenyltoloxamine HCl 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391614 | acetaminophen 325 MG / phenyltoloxamine HCl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2391614 | acetaminophen 325 MG / phenyltoloxamine HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391614 | acetaminophen 325 MG / phenyltoloxamine HCl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2391615 | guaiFENesin 200 MG / phenylpropanolamine HCl 45 MG / pseudoephedrine HCl 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2391615 | guaiFENesin 200 MG / phenylpropanolamine HCl 45 MG / pseudoephedrine HCl 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2391615 | guaiFENesin 200 MG / phenylpropanolamine HCl 45 MG / pseudoephedrine HCl 15 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2391615 | guaiFENesin 200 MG / phenylpropanolamine HCl 45 MG / pseudoephedrine HCl 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391615 | guaiFENesin 200 MG / phenylpropanolamine HCl 45 MG / pseudoephedrine HCl 15 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 239166 | glucose Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 239169 | saccharin 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2391745 | eicosapentaenoic acid 320 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2391746 | docosahexaenoic acid 200 MG / eicosapentaenoic acid 320 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391746 | docosahexaenoic acid 200 MG / eicosapentaenoic acid 320 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391746 | docosahexaenoic acid 200 MG / eicosapentaenoic acid 320 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2391748 | oxymetazoline hydrochloride 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2391749 | oxymetazoline hydrochloride 0.1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391749 | oxymetazoline hydrochloride 0.1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391749 | oxymetazoline hydrochloride 0.1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2391750 | Upneeq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2391751 | oxymetazoline hydrochloride 1 MG/ML [Upneeq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2391752 | oxymetazoline Ophthalmic Solution [Upneeq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2391753 | Upneeq Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2391754 | Upneeq 0.1 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2391754 | Upneeq 0.1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2391754 | Upneeq 0.1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2391754 | Upneeq 0.1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239177 | fluorouracil 50 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239178 | vinBLAStine sulfate 1 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239178 | vinBLAStine sulfate 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239178 | vinBLAStine sulfate 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239178 | vinBLAStine sulfate 1 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 239178 | vinBLAStine sulfate 1 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239178 | vinBLAStine sulfate 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239179 | DACTINomycin 500 MCG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239179 | DACTINomycin 500 MCG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 239179 | DACTINomycin 500 MCG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239179 | DACTINomycin 500 MCG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239179 | DACTINomycin 500 MCG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 239179 | DACTINomycin 500 MCG Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239179 | DACTINomycin 500 MCG Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239180 | streptozocin 1 GM Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239180 | streptozocin 1 GM Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239180 | streptozocin 1 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239180 | streptozocin 1 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239180 | streptozocin 1 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239186 | piperacillin (as piperacillin sodium) 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239186 | piperacillin (as piperacillin sodium) 200 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239186 | piperacillin (as piperacillin sodium) 200 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 239186 | piperacillin (as piperacillin sodium) 200 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 239186 | piperacillin (as piperacillin sodium) 200 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 239186 | piperacillin (as piperacillin sodium) 200 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 239187 | ampicillin 30 MG/ML / sulbactam 15 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239189 | nafcillin 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239189 | nafcillin 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239189 | nafcillin 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239191 | amoxicillin 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239191 | amoxicillin 250 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239191 | amoxicillin 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239191 | amoxicillin 250 MG in 5 mL Oral Suspension | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239191 | amoxicillin 250 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239191 | amoxicillin 250 MG in 5 mL Oral Suspension | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239194 | cefamandole 40 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239195 | cefonicid 325 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239200 | chloramphenicol 100 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239200 | chloramphenicol 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239200 | chloramphenicol 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239200 | chloramphenicol 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239200 | chloramphenicol 100 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239201 | kanamycin 250 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239202 | kanamycin 37.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2392030 | enrofloxacin 22.7 MG [Enrosite] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2392031 | enrofloxacin Oral Tablet [Enrosite] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2392032 | Enrosite Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2392033 | Enrosite Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2392034 | Enrosite 22.7 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2392034 | Enrosite 22.7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2392034 | Enrosite 22.7 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2392035 | enrofloxacin 68 MG [Enrosite] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2392036 | Enrosite 68 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2392036 | Enrosite 68 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2392036 | Enrosite 68 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2392037 | enrofloxacin 136 MG [Enrosite] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2392038 | Enrosite 136 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2392038 | Enrosite 136 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2392038 | Enrosite 136 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239204 | gentamicin sulfate 10 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239204 | gentamicin sulfate 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239204 | gentamicin sulfate 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239204 | gentamicin sulfate 10 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239207 | netilmicin (as netilmicin sulfate) 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239207 | netilmicin (as netilmicin sulfate) 100 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 239207 | netilmicin (as netilmicin sulfate) 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239207 | netilmicin (as netilmicin sulfate) 100 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 239208 | capreomycin 500 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239208 | capreomycin 500 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239208 | capreomycin 500 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239208 | capreomycin 500 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239208 | capreomycin 500 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239209 | vancomycin 100 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239209 | vancomycin 100 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239209 | vancomycin 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239209 | vancomycin 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239209 | vancomycin 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239211 | vancomycin (as vancomycin HCl) 500 MG per 6 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239211 | vancomycin (as vancomycin HCl) 500 MG per 6 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239212 | lincomycin 300 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239212 | lincomycin 300 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239212 | lincomycin 300 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2392131 | hydrogenated soybean phosphatidylcholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2392134 | butyl glycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2392135 | C30-38 olefin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2392136 | carbomer interpolymer type C (allyl sucrose crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2392138 | olive oil polyglyceryl-6 esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2392139 | etanercept Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2392140 | etanercept 25 MG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2392140 | etanercept 25 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2392140 | etanercept 25 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392141 | etanercept Injection [Enbrel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2392142 | Enbrel 25 MG in 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392142 | Enbrel 25 MG in 0.5 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2392142 | Enbrel 25 MG in 0.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2392142 | Enbrel 25 MG in 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392143 | etanercept 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2392144 | etanercept 50 MG/ML Injection [Enbrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2392144 | etanercept 50 MG/ML Injection [Enbrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2392230 | Oliceridine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2392230 | Oliceridine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2392230 | Oliceridine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2392230 | Oliceridine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2392230 | Oliceridine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2392234 | oliceridine 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392234 | oliceridine 1 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2392234 | oliceridine 1 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2392234 | oliceridine 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392235 | Olinvyk | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2392238 | Olinvyk Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2392239 | Olinvyk 1 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2392239 | Olinvyk 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392239 | Olinvyk 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392239 | Olinvyk 1 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2392239 | Olinvyk 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392240 | oliceridine 1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2392241 | oliceridine 1 MG/ML Injection [Olinvyk] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2392241 | oliceridine 1 MG/ML Injection [Olinvyk] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2392242 | oliceridine 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392242 | oliceridine 2 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2392242 | oliceridine 2 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2392242 | oliceridine 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392243 | Olinvyk 2 MG in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2392243 | Olinvyk 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392243 | Olinvyk 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392243 | Olinvyk 2 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2392243 | Olinvyk 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392244 | oliceridine 30 MG in 30 ML (For PCA Use Only) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392244 | oliceridine 30 MG in 30 ML (For PCA Use Only) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2392244 | oliceridine 30 MG in 30 ML (For PCA Use Only) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2392244 | oliceridine 30 MG in 30 ML (For PCA Use Only) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392245 | Olinvyk 30 MG in 30 ML (For PCA Use Only) Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2392245 | Olinvyk 30 MG in 30 ML (For PCA Use Only) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392245 | Olinvyk 30 MG in 30 ML (For PCA Use Only) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2392245 | Olinvyk 30 MG in 30 ML (For PCA Use Only) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2392245 | Olinvyk 30 MG in 30 ML (For PCA Use Only) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239226 | hyoscyamine / methenamine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 239233 | methionine 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 239233 | methionine 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239236 | dimethyl sulfoxide 99 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239236 | dimethyl sulfoxide 99 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239237 | griseofulvin 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 239237 | griseofulvin 250 MG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 239237 | griseofulvin 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239237 | griseofulvin 250 MG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 239237 | griseofulvin 250 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 239237 | griseofulvin 250 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 239238 | griseofulvin 125 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239238 | griseofulvin 125 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239238 | griseofulvin 125 MG in 5 mL Oral Suspension | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239238 | griseofulvin 125 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239238 | griseofulvin 125 MG in 5 mL Oral Suspension | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239239 | griseofulvin 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239239 | griseofulvin 250 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239239 | griseofulvin 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239239 | griseofulvin 250 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239239 | griseofulvin 250 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239239 | griseofulvin 250 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239239 | griseofulvin 250 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239239 | griseofulvin 250 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239240 | amphotericin B 50 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239240 | amphotericin B 50 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239240 | amphotericin B 50 MG Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239240 | amphotericin B 50 MG Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239241 | nystatin 1 Million UNT Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239241 | nystatin 1 Million UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239241 | nystatin 1 Million UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239241 | nystatin 1 Million UNT Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2392630 | C8-10/propylene glycol/peg-22/decylene glycol ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2392631 | ocean quahog extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2392632 | sodium 2-acrylamido-2-methyl-1-propane sulfonate/sodium acrylate/n-isopropylacrylamide/trimethyl(3-methacrylamidopropyl)ammonium chloride copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2392633 | oliceridine fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2392633 | oliceridine fumarate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2392633 | oliceridine fumarate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23927 | embelin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2392730 | oxybate Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2392731 | oxybate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 239293 | Hymenoptera allergenic extract 0.1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239295 | honey bee venom allergenic extract 0.3 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 239295 | honey bee venom allergenic extract 0.3 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393 | Chloroquine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2393 | Chloroquine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2393 | Chloroquine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2393 | Chloroquine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2393 | Chloroquine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2393130 | isopropyl alcohol 72 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393130 | isopropyl alcohol 72 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393130 | isopropyl alcohol 72 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239342 | dextran 70 320 MG/ML Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239351 | liquefied phenol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2393522 | 1,1-bis(tert-butylperoxy)cyclohexane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2393523 | gamma-terpinene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2393524 | sodium nitrate N-15 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2393524 | sodium nitrate N-15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2393525 | Lonicera hypoglauca whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2393526 | dimethyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2393527 | dimethyl methylglutarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2393529 | dimethyl glutarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 239353 | glutaral 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 239353 | glutaral 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239353 | glutaral 25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393532 | ditiocarb silver | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2393534 | trimethylolpropane trioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2393535 | camphor 4 % / menthol 6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393535 | camphor 4 % / menthol 6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393535 | camphor 4 % / menthol 6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2393577 | ethanol 0.696 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2393578 | ethanol 69.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393578 | ethanol 69.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393578 | ethanol 69.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2393579 | benzalkonium chloride 3.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2393580 | benzalkonium chloride 0.33 % / ethanol 80 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393580 | benzalkonium chloride 0.33 % / ethanol 80 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2393580 | benzalkonium chloride 0.33 % / ethanol 80 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393581 | dimethyl succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2393583 | monomethyl fumarate 95 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2393584 | monomethyl fumarate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2393584 | monomethyl fumarate Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2393584 | monomethyl fumarate Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2393585 | monomethyl fumarate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2393586 | monomethyl fumarate Delayed Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2393587 | monomethyl fumarate 95 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2393587 | monomethyl fumarate 95 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2393587 | monomethyl fumarate 95 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2393587 | monomethyl fumarate 95 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2393588 | Bafiertam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2393589 | monomethyl fumarate 95 MG [Bafiertam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2393590 | monomethyl fumarate Delayed Release Oral Capsule [Bafiertam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2393591 | Bafiertam Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2393592 | Bafiertam Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2393593 | Bafiertam 95 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2393593 | Bafiertam 95 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393593 | Bafiertam 95 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2393596 | camphor 0.047 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2393597 | camphor 4.7 % / menthol 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393597 | camphor 4.7 % / menthol 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393597 | camphor 4.7 % / menthol 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2393602 | camphor 0.03 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2393603 | menthol 0.05 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2393604 | camphor 3 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393604 | camphor 3 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393604 | camphor 3 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2393605 | Streptococcus salivarius | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2393609 | calcium oxybate 234 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2393610 | magnesium oxybate 96 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2393611 | potassium oxybate 130 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2393612 | sodium oxybate 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2393774 | pulegone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2393778 | .beta.-pinene, (+)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2393779 | isoeugenyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2393781 | aspirin 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2393782 | aspirin Oral Spray Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2393783 | aspirin Oral Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2393784 | aspirin 6 MG/ML Oral Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2393784 | aspirin 6 MG/ML Oral Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393784 | aspirin 6 MG/ML Oral Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393788 | ethanol 76 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393788 | ethanol 76 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393788 | ethanol 76 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2393794 | xywav 0.5 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393794 | xywav 0.5 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393794 | xywav 0.5 GM in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2393794 | xywav 0.5 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393794 | xywav 0.5 GM in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2393794 | xywav 0.5 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393795 | calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2393795 | calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393795 | calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393795 | calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393795 | calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2393795 | calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2393795 | calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2393795 | calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2393796 | calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2393796 | calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2393796 | calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2393797 | Xywav Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2393798 | Xywav Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2393799 | calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / potassium oxybate 130 MG/ML / sodium oxybate 40 MG/ML [Xywav] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2393800 | Xywav | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2393801 | oxybate Oral Solution [Xywav] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2393805 | ethanol 73 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2393805 | ethanol 73 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2393805 | ethanol 73 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394040 | cupric citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2394041 | acetaminophen / diphenhydramine Effervescent Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2394041 | acetaminophen / diphenhydramine Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2394042 | acetaminophen 500 MG / diphenhydrAMINE hydrochloride 25 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394042 | acetaminophen 500 MG / diphenhydrAMINE hydrochloride 25 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394042 | acetaminophen 500 MG / diphenhydrAMINE hydrochloride 25 MG Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2394042 | acetaminophen 500 MG / diphenhydrAMINE hydrochloride 25 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394042 | acetaminophen 500 MG / diphenhydrAMINE hydrochloride 25 MG Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2394049 | camphor 0.5 % / menthol 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394049 | camphor 0.5 % / menthol 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394049 | camphor 0.5 % / menthol 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394056 | aspirin / menthol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2394057 | aspirin 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2394058 | aspirin / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2394059 | aspirin / menthol Oral Lozenge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2394060 | aspirin / menthol Lozenge Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2394061 | aspirin 6 MG / menthol 5 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394061 | aspirin 6 MG / menthol 5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394061 | aspirin 6 MG / menthol 5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 23944 | emepronium carrageenate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2394439 | butyl butyryl lactate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394439 | butyl butyryl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2394448 | benzalkonium chloride 0.14 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394448 | benzalkonium chloride 0.14 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394448 | benzalkonium chloride 0.14 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394449 | benzalkonium chloride 3.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2394450 | benzalkonium Cl 0.37 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394450 | benzalkonium Cl 0.37 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394450 | benzalkonium Cl 0.37 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394451 | benzalkonium chloride 0.24 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394451 | benzalkonium chloride 0.24 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394451 | benzalkonium chloride 0.24 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394495 | benzalkonium / ethanol / isopropyl alcohol Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2394496 | benzalkonium / ethanol / isopropyl alcohol Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2394497 | benzalkonium chloride 0.2 % / ethanol 58 % / isopropyl alcohol 12 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394497 | benzalkonium chloride 0.2 % / ethanol 58 % / isopropyl alcohol 12 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394497 | benzalkonium chloride 0.2 % / ethanol 58 % / isopropyl alcohol 12 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394498 | isopropyl alcohol 0.73 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2394499 | isopropyl alcohol 73 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394499 | isopropyl alcohol 73 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394499 | isopropyl alcohol 73 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394500 | 2,4-diaminophenoxyethanol sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2394501 | 1-hexadecyl-5-ethyl-2-methylpyridinium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2394502 | camphor 0.0316 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2394503 | camphor 3.16 % / capsaicin 0.03 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394503 | camphor 3.16 % / capsaicin 0.03 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394503 | camphor 3.16 % / capsaicin 0.03 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394504 | sulfur, colloidal 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2394505 | sulfur, colloidal Soap Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2394506 | sulfur, colloidal Medicated Liquid Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2394507 | colloidal sulfur 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2394507 | colloidal sulfur 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2394507 | colloidal sulfur 1 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2394645 | 2-ethylhexanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2394646 | pantothenic acid, (+-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2394936 | pralsetinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2394936 | pralsetinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2394936 | pralsetinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2394936 | pralsetinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2394936 | pralsetinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2394937 | pralsetinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2394938 | pralsetinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2394938 | pralsetinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2394938 | pralsetinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2394939 | pralsetinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2394940 | pralsetinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2394941 | pralsetinib 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2394941 | pralsetinib 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2394941 | pralsetinib 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2394941 | pralsetinib 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2394942 | Gavreto | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2394943 | pralsetinib 100 MG [Gavreto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2394944 | pralsetinib Oral Capsule [Gavreto] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2394945 | Gavreto Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2394946 | Gavreto Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2394947 | GAVRETO 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2394947 | GAVRETO 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2394947 | GAVRETO 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2394950 | Ribes rubrum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23950 | EMLA | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2395089 | 2 ML fibrinogen, human 90 MG/ML / thrombin, human 500 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395091 | 2 ML fibrinogen, human 90 MG/ML / thrombin, human 500 UNT/ML Prefilled Syringe [Tisseel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2395092 | fibrinogen, human 90 MG/ML / thrombin, human 500 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395093 | fibrinogen, human 90 MG/ML / thrombin, human 500 UNT/ML Prefilled Syringe [Tisseel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2395271 | sapanisertib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2395426 | benzalkonium Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2395427 | benzalkonium chloride 0.13 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395427 | benzalkonium chloride 0.13 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2395427 | benzalkonium chloride 0.13 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2395436 | 4-N-octylphenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395438 | ethanol 0.86 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2395439 | ethanol 86 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395439 | ethanol 86 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2395439 | ethanol 86 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2395440 | Eremophila scoparia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395441 | ethanol 86 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395441 | ethanol 86 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2395441 | ethanol 86 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2395446 | PEG-5 cocamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395471 | benzalkonium chloride 0.1 % / ethanol 70 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2395471 | benzalkonium chloride 0.1 % / ethanol 70 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2395471 | benzalkonium chloride 0.1 % / ethanol 70 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395498 | Veklury | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2395499 | remdesivir 100 MG [Veklury] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395500 | remdesivir Injection [Veklury] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395501 | Veklury Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2395502 | Veklury 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395502 | Veklury 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395502 | Veklury 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395503 | remdesivir 5 MG/ML [Veklury] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395504 | Veklury 100 MG in 20 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395504 | Veklury 100 MG in 20 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395504 | Veklury 100 MG in 20 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395504 | Veklury 100 MG in 20 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395505 | remdesivir 5 MG/ML Injection [Veklury] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2395505 | remdesivir 5 MG/ML Injection [Veklury] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2395758 | hypromellose 2208 (1500 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395759 | disperse red 15 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395760 | 3-carene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395761 | Camphene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395761 | Camphene | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2395761 | Camphene | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2395761 | Camphene | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2395761 | Camphene | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2395762 | hexahydro-4,7-methanoinden-6-yl propionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395763 | 1-octen-3-ol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395764 | 2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentan-1-one | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395765 | diethyl malonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2395766 | neryl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2395767 | 3,5,5-trimethylhexyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395768 | 1-octen-3-yl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395769 | fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395769 | fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395769 | fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395770 | fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT [Trelegy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395771 | TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395771 | TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395771 | TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395772 | fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395773 | fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2395774 | fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395774 | fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395774 | fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395775 | TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395775 | TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395775 | TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395776 | dulaglutide 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2395777 | dulaglutide 3 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395777 | dulaglutide 3 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395777 | dulaglutide 3 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395777 | dulaglutide 3 MG in 0.5 ML Auto-Injector | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2395777 | dulaglutide 3 MG in 0.5 ML Auto-Injector | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2395778 | dulaglutide 6 MG/ML [Trulicity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395779 | Trulicity 3 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395779 | Trulicity 3 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395779 | Trulicity 3 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395779 | Trulicity 3 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395780 | dulaglutide 6 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395781 | dulaglutide 6 MG/ML Auto-Injector [Trulicity] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2395781 | dulaglutide 6 MG/ML Auto-Injector [Trulicity] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2395782 | dulaglutide 9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2395783 | dulaglutide 4.5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395783 | dulaglutide 4.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395783 | dulaglutide 4.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395783 | dulaglutide 4.5 MG in 0.5 ML Auto-Injector | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2395783 | dulaglutide 4.5 MG in 0.5 ML Auto-Injector | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2395784 | dulaglutide 9 MG/ML [Trulicity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395785 | Trulicity 4.5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395785 | Trulicity 4.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395785 | Trulicity 4.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395785 | Trulicity 4.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395786 | dulaglutide 9 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2395787 | dulaglutide 9 MG/ML Auto-Injector [Trulicity] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2395787 | dulaglutide 9 MG/ML Auto-Injector [Trulicity] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2395788 | bupivacaine hydrochloride 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2395788 | bupivacaine hydrochloride 100 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395789 | bupivacaine Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2395789 | bupivacaine Drug Implant Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395790 | bupivacaine Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2395790 | bupivacaine Drug Implant | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395791 | BUPivacaine HCl 100 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395791 | BUPivacaine HCl 100 MG Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395791 | BUPivacaine HCl 100 MG Drug Implant | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395792 | BUPivacaine HCl 100 MG Drug Implant, 3 Implant Dose | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2395792 | BUPivacaine HCl 100 MG Drug Implant, 3 Implant Dose | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395792 | BUPivacaine HCl 100 MG Drug Implant, 3 Implant Dose | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395792 | BUPivacaine HCl 100 MG Drug Implant, 3 Implant Dose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395792 | BUPivacaine HCl 100 MG Drug Implant, 3 Implant Dose | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395792 | BUPivacaine HCl 100 MG Drug Implant, 3 Implant Dose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395792 | BUPivacaine HCl 100 MG Drug Implant, 3 Implant Dose | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395793 | Xaracoll | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2395794 | bupivacaine hydrochloride 100 MG [Xaracoll] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395794 | bupivacaine hydrochloride 100 MG [Xaracoll] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395795 | bupivacaine Drug Implant [Xaracoll] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395795 | bupivacaine Drug Implant [Xaracoll] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395796 | Xaracoll Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2395797 | Xaracoll 100 MG Drug Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395797 | Xaracoll 100 MG Drug Implant | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395797 | Xaracoll 100 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395797 | Xaracoll 100 MG Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395798 | xaracoll 3 x 100 MG Implant Dose Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2395798 | xaracoll 3 x 100 MG Implant Dose Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395798 | xaracoll 3 x 100 MG Implant Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395798 | xaracoll 3 x 100 MG Implant Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395800 | .alpha.-amylcinnamyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2395801 | .beta.-caryophyllene oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395802 | bornyl acetate, (-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2395807 | tramadol hydrochloride 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2395807 | tramadol hydrochloride 5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395808 | traMADol hydrochloride 5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395808 | traMADol hydrochloride 5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395808 | traMADol hydrochloride 5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395808 | traMADol hydrochloride 5 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395808 | traMADol hydrochloride 5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395809 | Qdolo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2395810 | tramadol hydrochloride 5 MG/ML [Qdolo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395810 | tramadol hydrochloride 5 MG/ML [Qdolo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395811 | tramadol Oral Solution [Qdolo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395811 | tramadol Oral Solution [Qdolo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395812 | Qdolo Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2395813 | Qdolo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2395814 | QDOLO 5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395814 | QDOLO 5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395814 | QDOLO 5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395814 | QDOLO 5 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395814 | QDOLO 5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2395825 | salmeterol 0.014 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2395826 | fluticasone propionate/salmeterol 113/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395826 | fluticasone propionate/salmeterol 113/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395826 | fluticasone propionate/salmeterol 113/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395827 | fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT [AirDuo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395828 | AirDuo digihaler 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395828 | AirDuo digihaler 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395828 | AirDuo digihaler 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395828 | AirDuo digihaler 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395829 | fluticasone propionate/salmeterol 55/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395829 | fluticasone propionate/salmeterol 55/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395829 | fluticasone propionate/salmeterol 55/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395830 | fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT [AirDuo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395831 | AirDuo digihaler 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395831 | AirDuo digihaler 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395831 | AirDuo digihaler 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395831 | AirDuo digihaler 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395832 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395832 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395832 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395833 | fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT [AirDuo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2395834 | AirDuo digihaler 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395834 | AirDuo digihaler 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395834 | AirDuo digihaler 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395835 | fluticasone propionate 113 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395835 | fluticasone propionate 113 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395835 | fluticasone propionate 113 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395836 | ArmonAir digihaler 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395836 | ArmonAir digihaler 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395836 | ArmonAir digihaler 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395836 | ArmonAir digihaler 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395837 | fluticasone propionate 232 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395837 | fluticasone propionate 232 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395837 | fluticasone propionate 232 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395838 | ArmonAir digihaler 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395838 | ArmonAir digihaler 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395838 | ArmonAir digihaler 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395838 | ArmonAir digihaler 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395839 | fluticasone propionate 55 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395839 | fluticasone propionate 55 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395839 | fluticasone propionate 55 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395840 | ArmonAir digihaler 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395840 | ArmonAir digihaler 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395840 | ArmonAir digihaler 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2395840 | ArmonAir digihaler 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2395841 | nifurtimox 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2395842 | nifurtimox 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2395842 | nifurtimox 30 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2395842 | nifurtimox 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2395842 | nifurtimox 30 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2396 | Chlorothiazide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2396 | Chlorothiazide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2396 | Chlorothiazide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2396 | Chlorothiazide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2396 | Chlorothiazide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2396017 | benzalkonium chloride 0.1 % / ethanol 15 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2396017 | benzalkonium chloride 0.1 % / ethanol 15 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396017 | benzalkonium chloride 0.1 % / ethanol 15 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396018 | C9-11 alkane/cycloalkane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2396039 | petrolatum 0.78 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2396040 | zinc oxide 0.076 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2396041 | petrolatum 77.99 % / zinc oxide 7.6 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396041 | petrolatum 77.99 % / zinc oxide 7.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396041 | petrolatum 77.99 % / zinc oxide 7.6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2396041 | petrolatum 77.99 % / zinc oxide 7.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396231 | benzalkonium chloride 0.000165 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2396232 | benzalkonium / ethanol Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2396233 | benzalkonium chloride 0.0165 % / ethanol 71 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396233 | benzalkonium chloride 0.0165 % / ethanol 71 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2396233 | benzalkonium chloride 0.0165 % / ethanol 71 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396234 | ethanol 0.778 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2396235 | ethanol 77.76 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396235 | ethanol 77.76 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2396235 | ethanol 77.76 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396237 | ethinyl estradiol 0.00125 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2396238 | levonorgestrel 0.005 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2396239 | ethinyl estradiol / levonorgestrel Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2396240 | ethinyl estradiol / levonorgestrel Transdermal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2396241 | ethinyl estradiol / levonorgestrel Transdermal System | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2396242 | ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2396242 | ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396251 | ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396253 | ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System, 3 Count | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2396253 | ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System, 3 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396254 | ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR [Twirla] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2396255 | ethinyl estradiol / levonorgestrel Transdermal System [Twirla] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396256 | Twirla Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2396257 | Twirla Transdermal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2396258 | Twirla Weekly Replacement Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396258 | Twirla Weekly Replacement Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396258 | Twirla Weekly Replacement Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396259 | Twirla 3 Count Weekly Transdermal System | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2396259 | Twirla 3 Count Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396259 | Twirla 3 Count Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396260 | ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR Transdermal System [Twirla] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2396261 | ethanol 63 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396261 | ethanol 63 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2396261 | ethanol 63 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396262 | ethanol 0.55 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2396263 | isopropyl alcohol 0.15 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2396264 | benzalkonium chloride 0.0165 % / ethanol 55 % / isopropyl alcohol 15 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396264 | benzalkonium chloride 0.0165 % / ethanol 55 % / isopropyl alcohol 15 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2396264 | benzalkonium chloride 0.0165 % / ethanol 55 % / isopropyl alcohol 15 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396430 | 1-(2,3,8,8-tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)ethanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396431 | allyl ionone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2396431 | allyl ionone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396433 | glycereth-8 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396434 | methyl 3-methylorsellinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2396435 | polyglycerin-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396437 | .beta.-pinene, (-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2396442 | copper CU-64 dotatate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2396442 | copper CU-64 dotatate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2396442 | copper CU-64 dotatate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2396442 | copper CU-64 dotatate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396442 | copper CU-64 dotatate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2396442 | copper CU-64 dotatate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2396443 | dodatate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396444 | Bronkaid Max | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2396445 | ephedrine sulfate 25 MG [Bronkaid Max] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2396445 | ephedrine sulfate 25 MG [Bronkaid Max] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396446 | ephedrine Oral Tablet [Bronkaid Max] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396446 | ephedrine Oral Tablet [Bronkaid Max] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396447 | Bronkaid Max Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2396448 | Bronkaid Max Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2396449 | Bronkaid Max 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396449 | Bronkaid Max 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396449 | Bronkaid Max 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396449 | Bronkaid Max 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 23965 | Endo-1,3-alpha-glucanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23965 | Endo-1,3-alpha-glucanase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23965 | Endo-1,3-alpha-glucanase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23966 | Endo-1,3-beta-xylanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23966 | Endo-1,3-beta-xylanase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23966 | Endo-1,3-beta-xylanase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23966 | Endo-1,3-beta-xylanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23967 | Endo-1,4-beta-mannanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23967 | Endo-1,4-beta-mannanase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23967 | Endo-1,4-beta-mannanase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2396753 | benzalkonium chloride 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2396753 | benzalkonium chloride 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396753 | benzalkonium chloride 1 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396755 | caprylaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396756 | ethyl anthranilate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396758 | 2-methyl-2-methylamino-1-propanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396759 | octoxynol-8 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396760 | azacitidine 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2396760 | azacitidine 200 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396761 | azacitidine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2396761 | azacitidine Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396761 | azacitidine Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2396761 | azacitidine Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2396762 | azacitidine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2396762 | azacitidine Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396763 | azacitidine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2396763 | azacitidine Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396764 | azaCITIDine 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396764 | azaCITIDine 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2396764 | azaCITIDine 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2396764 | azaCITIDine 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396764 | azaCITIDine 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2396765 | Onureg | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2396766 | azacitidine 200 MG [Onureg] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2396766 | azacitidine 200 MG [Onureg] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396767 | azacitidine Oral Tablet [Onureg] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396767 | azacitidine Oral Tablet [Onureg] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396768 | Onureg Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2396769 | Onureg Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2396770 | Onureg 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396770 | Onureg 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396770 | Onureg 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396770 | Onureg 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396771 | azacitidine 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2396771 | azacitidine 300 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396772 | azaCITIDine 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396772 | azaCITIDine 300 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2396772 | azaCITIDine 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2396772 | azaCITIDine 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396772 | azaCITIDine 300 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2396773 | azacitidine 300 MG [Onureg] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2396773 | azacitidine 300 MG [Onureg] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396774 | Onureg 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396774 | Onureg 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396774 | Onureg 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396774 | Onureg 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396781 | .alpha.-chlorohydrin, (+/-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2396782 | .delta.-damascone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396784 | collagen alpha-1(I) chain (bovine) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396787 | lidocaine Topical Spray [Regenecare] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 23968 | Endo-1,4-beta-xylanase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23968 | Endo-1,4-beta-xylanase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2396889 | PEG-200 glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2396890 | 3-chloro-2-hydroxypropylcocoalkyldimethylammonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2396891 | dexmedeTOMIDine 1000 MG in 250 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2396891 | dexmedeTOMIDine 1000 MG in 250 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396891 | dexmedeTOMIDine 1000 MG in 250 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396891 | dexmedeTOMIDine 1000 MG in 250 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396891 | dexmedeTOMIDine 1000 MG in 250 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396891 | dexmedeTOMIDine 1000 MG in 250 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396891 | dexmedeTOMIDine 1000 MG in 250 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396892 | Precedex 1000 MCG in 250 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396892 | Precedex 1000 MCG in 250 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396892 | Precedex 1000 MCG in 250 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396892 | Precedex 1000 MCG in 250 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396892 | Precedex 1000 MCG in 250 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396895 | diphenhydramine hydrochloride 0.02 MG/MG [The Itch Eraser] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2396895 | diphenhydramine hydrochloride 0.02 MG/MG [The Itch Eraser] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396896 | diphenhydramine Topical Gel [The Itch Eraser] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396896 | diphenhydramine Topical Gel [The Itch Eraser] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396897 | The Itch Eraser 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396897 | The Itch Eraser 2 % Topical Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2396897 | The Itch Eraser 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396897 | The Itch Eraser 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396897 | The Itch Eraser 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 23969 | Endo-1,6-beta-glucanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23969 | Endo-1,6-beta-glucanase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23969 | Endo-1,6-beta-glucanase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2396900 | cysteamine 0.37 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396900 | cysteamine 0.37 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396900 | cysteamine 0.37 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2396901 | Cystadrops | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2396903 | cysteamine Ophthalmic Solution [Cystadrops] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396904 | Cystadrops Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2396905 | Cystadrops 0.37 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2396905 | Cystadrops 0.37 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396905 | Cystadrops 0.37 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396905 | Cystadrops 0.37 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2396905 | Cystadrops 0.37 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2396906 | Prasugrel besilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396906 | Prasugrel besilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2396906 | Prasugrel besilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2396990 | colloidal oatmeal 1.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2396990 | colloidal oatmeal 1.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2396990 | colloidal oatmeal 1.5 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2396994 | lidocaine hydrochloride 20 MG/ML [Regenecare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2397 | Chlorotrianisene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397 | Chlorotrianisene | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2397 | Chlorotrianisene | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2397 | Chlorotrianisene | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2397 | Chlorotrianisene | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2397003 | Minocycline-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2397003 | Minocycline-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2397114 | Fragaria vesca fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397119 | dipotassium aspartate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2397120 | dipotassium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397121 | Sambucus nigra seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397126 | pigment violet 23 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397128 | Lyleq 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2397128 | Lyleq 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2397128 | Lyleq 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2397131 | ethanol 70 % / isopropyl alcohol 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397131 | ethanol 70 % / isopropyl alcohol 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397131 | ethanol 70 % / isopropyl alcohol 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397132 | 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) / 1 daytime (acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2397132 | 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) / 1 daytime (acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2397132 | 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) / 1 daytime (acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2397132 | 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) / 1 daytime (acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2397132 | 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) / 1 daytime (acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2397230 | carprofen Chewable Tablet [Carprovet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2397231 | Carprovet Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2397232 | Carprovet 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2397232 | Carprovet 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397232 | Carprovet 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397233 | Carprovet 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2397233 | Carprovet 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397233 | Carprovet 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397234 | Carprovet 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2397234 | Carprovet 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397234 | Carprovet 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397247 | sodium chloride / sodium citrate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2397248 | sodium chloride 5.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2397249 | Regiocit | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2397250 | NaCl 5.03 MG/ML / sodium citrate 5.29 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397250 | NaCl 5.03 MG/ML / sodium citrate 5.29 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397251 | citrate 18 mmol / sodium 140 mmol in L Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2397251 | citrate 18 mmol / sodium 140 mmol in L Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2397251 | citrate 18 mmol / sodium 140 mmol in L Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2397251 | citrate 18 mmol / sodium 140 mmol in L Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2397252 | sodium chloride 5.03 MG/ML / sodium citrate 5.29 MG/ML [Regiocit] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2397253 | sodium citrate 5.29 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2397254 | sodium chloride / sodium citrate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2397255 | sodium chloride / sodium citrate Injection [Regiocit] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2397256 | Regiocit Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2397257 | REGIOCIT (citrate 18 mmol / sodium 140 mmol in 1 L) 5000 ML Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2397257 | REGIOCIT (citrate 18 mmol / sodium 140 mmol in 1 L) 5000 ML Injection (EUA) | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2397257 | REGIOCIT (citrate 18 mmol / sodium 140 mmol in 1 L) 5000 ML Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2397257 | REGIOCIT (citrate 18 mmol / sodium 140 mmol in 1 L) 5000 ML Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2397258 | sodium chloride / sodium citrate Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2397259 | sodium chloride 5.03 MG/ML / sodium citrate 5.29 MG/ML Injection [Regiocit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397259 | sodium chloride 5.03 MG/ML / sodium citrate 5.29 MG/ML Injection [Regiocit] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2397685 | ethanol 0.04 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2397686 | benzalkonium chloride 0.13 % / ethanol 4 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397686 | benzalkonium chloride 0.13 % / ethanol 4 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397686 | benzalkonium chloride 0.13 % / ethanol 4 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397687 | ceteareth-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397688 | octoxynol-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397689 | precyclemone B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397690 | tert-butyl methylphenoxy phenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397693 | ethanol 63.5 % / isopropyl alcohol 2.8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397693 | ethanol 63.5 % / isopropyl alcohol 2.8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397693 | ethanol 63.5 % / isopropyl alcohol 2.8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397694 | ethanol 76 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397694 | ethanol 76 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397694 | ethanol 76 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397695 | hydrogen peroxide 1.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2397696 | ethanol / hydrogen peroxide Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2397697 | ethanol / hydrogen peroxide Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2397698 | ethanol 70 % / hydrogen peroxide 0.125 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397698 | ethanol 70 % / hydrogen peroxide 0.125 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397698 | ethanol 70 % / hydrogen peroxide 0.125 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397699 | isopropyl alcohol 80 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397699 | isopropyl alcohol 80 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397699 | isopropyl alcohol 80 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397705 | ethyl butylacetylaminopropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397706 | benzalkonium chloride 0.1 % / ethanol 4 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397706 | benzalkonium chloride 0.1 % / ethanol 4 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397706 | benzalkonium chloride 0.1 % / ethanol 4 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397707 | ethanol 0.607 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2397708 | isopropyl alcohol 0.087 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2397709 | ethanol 60.7 % / isopropyl alcohol 8.7 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397709 | ethanol 60.7 % / isopropyl alcohol 8.7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397709 | ethanol 60.7 % / isopropyl alcohol 8.7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397710 | trans-3-isocamphylcyclohexanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2397711 | menthol 0.024 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2397712 | menthol 2.4 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397712 | menthol 2.4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397712 | menthol 2.4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397714 | succinylcholine chloride dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2397715 | 2-azetidinecarboxylic acid, (+)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397718 | ethanol 70 % / isopropyl alcohol 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397718 | ethanol 70 % / isopropyl alcohol 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397718 | ethanol 70 % / isopropyl alcohol 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397740 | COVID-19 mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397740 | COVID-19 mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397740 | COVID-19 mRNA vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2397740 | COVID-19 mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397740 | COVID-19 mRNA vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2397768 | isopropyl alcohol 0.07 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2397769 | ethanol 63 % / isopropyl alcohol 7 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397769 | ethanol 63 % / isopropyl alcohol 7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397769 | ethanol 63 % / isopropyl alcohol 7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397984 | Nymphaea alba root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397985 | 1,2-dierucoyl-sn-glycero-3(phospho-rac-(1-glycerol)) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2397986 | Lampit | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2397987 | nifurtimox 30 MG [Lampit] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2397988 | nifurtimox Oral Tablet [Lampit] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2397989 | Lampit Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2397990 | Lampit Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2397991 | Lampit 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2397991 | Lampit 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2397991 | Lampit 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2397992 | camphor 5 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2397992 | camphor 5 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2397992 | camphor 5 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2397993 | nifurtimox 120 MG [Lampit] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2397994 | Lampit 120 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2397994 | Lampit 120 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2397994 | Lampit 120 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2398130 | polatuzumab vedotin-piiq 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2398131 | olatuzumab vedotin-piiq 30 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2398131 | olatuzumab vedotin-piiq 30 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2398132 | polatuzumab vedotin-piiq 30 MG [Polivy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2398133 | Polivy 30 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2398133 | Polivy 30 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2398133 | Polivy 30 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2398144 | cycloastragenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2398145 | Acacia seyal whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2398178 | benzalkonium Cl 0.125 % / ethanol 5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398178 | benzalkonium Cl 0.125 % / ethanol 5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2398178 | benzalkonium Cl 0.125 % / ethanol 5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 23982 | Endodeoxyribonuclease (pyrimidine dimer) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23982 | Endodeoxyribonuclease (pyrimidine dimer) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23982 | Endodeoxyribonuclease (pyrimidine dimer) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398330 | isobornyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2398332 | alpha-damascone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2398333 | silodrate, anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2398334 | linalyl acetate, (-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2398335 | borneol, (-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2398336 | alpha-terpinyl acetate, (-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2398338 | alpha-terpineol, (+)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2398340 | phenol 0.6 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2398340 | phenol 0.6 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398340 | phenol 0.6 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2398341 | ethanol 95 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2398341 | ethanol 95 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2398341 | ethanol 95 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398387 | benzalkonium chloride 0.05 % / ethanol 65 % / isopropyl alcohol 10 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2398387 | benzalkonium chloride 0.05 % / ethanol 65 % / isopropyl alcohol 10 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398387 | benzalkonium chloride 0.05 % / ethanol 65 % / isopropyl alcohol 10 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2398511 | gabapentin sample pack 300 MG (9), 600 MG (24) Once-Daily Oral Tablet | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2398511 | gabapentin sample pack 300 MG (9), 600 MG (24) Once-Daily Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2398511 | gabapentin sample pack 300 MG (9), 600 MG (24) Once-Daily Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2398512 | Gralise Sample Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2398512 | Gralise Sample Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2398512 | Gralise Sample Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2398513 | Canarium indicum seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2398514 | Chrysanthemum zawadskii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2398515 | diethylene glycol ethyl methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2398518 | salicylic acid 0.01 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2398518 | salicylic acid 0.01 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398518 | salicylic acid 0.01 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2398528 | cysteamine 3.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2398530 | cysteamine 3.8 MG/ML [Cystadrops] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2398835 | dimethyl diallyl ammonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2398841 | semaglutide 4 MG in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2398841 | semaglutide 4 MG in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2398841 | semaglutide 4 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2398842 | OZEMPIC 4 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2398842 | OZEMPIC 4 MG in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2398842 | OZEMPIC 4 MG in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2398843 | semaglutide 1.34 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2398844 | semaglutide 1.34 MG/ML Pen Injector [Ozempic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398844 | semaglutide 1.34 MG/ML Pen Injector [Ozempic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2398846 | ethanol 0.827 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2398847 | ethanol 82.7 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2398847 | ethanol 82.7 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2398847 | ethanol 82.7 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398848 | benzalkonium chloride 0.1 % / ethanol 85 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2398848 | benzalkonium chloride 0.1 % / ethanol 85 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398848 | benzalkonium chloride 0.1 % / ethanol 85 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2398849 | benzalkonium chloride 1.21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2398850 | benzalkonium chloride 0.121 % Topical Swab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398850 | benzalkonium chloride 0.121 % Topical Swab | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2398850 | benzalkonium chloride 0.121 % Topical Swab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2398850 | benzalkonium chloride 0.121 % Topical Swab | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2399 | Chlorphenesin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2399 | Chlorphenesin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2399 | Chlorphenesin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2399 | Chlorphenesin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2399 | Chlorphenesin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2399027 | hexapeptide-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2399028 | alpha-succinimidyloxy carbonyl-omega-methoxy, polyoxyethylene MW 5000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2399029 | polyglyceryl-5 trioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2399030 | tributyl phosphite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2399031 | chitosan succinamide (1300 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2399032 | PEG-8 beeswax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2399104 | Triplicin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2399105 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Triplicin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2399106 | bacitracin / neomycin / polymyxin B Ophthalmic Ointment [Triplicin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399107 | Triplicin Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2399108 | TRIPLICIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399108 | TRIPLICIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399108 | TRIPLICIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2399230 | benzalkonium chloride 0.05 % / ethanol 70 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2399230 | benzalkonium chloride 0.05 % / ethanol 70 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399230 | benzalkonium chloride 0.05 % / ethanol 70 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2399530 | benzalkonium chloride 0.1 % / lidocaine 5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2399530 | benzalkonium chloride 0.1 % / lidocaine 5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399530 | benzalkonium chloride 0.1 % / lidocaine 5 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2399544 | Rubus corchorifolius whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2399545 | tetrapeptide-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2399546 | Eucalyptus smithii oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2399551 | benzyldimethyloctylammonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2399552 | octyldimethylammonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2399553 | sodium taurine laurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2399555 | mu-conotoxin G IIIC | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2399559 | ethanol 0.705 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2399560 | ethanol 70.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2399560 | ethanol 70.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2399560 | ethanol 70.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399561 | ethanol 0.722 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2399562 | ethanol 72.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2399562 | ethanol 72.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399562 | ethanol 72.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2399562 | ethanol 72.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399563 | isopropyl alcohol 76 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2399563 | isopropyl alcohol 76 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2399563 | isopropyl alcohol 76 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399634 | citicoline Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2399635 | citicoline 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399635 | citicoline 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2399641 | hydrocortisone 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2399642 | hydrocortisone Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2399643 | hydrocortisone Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2399644 | hydrocortisone 0.5 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399644 | hydrocortisone 0.5 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2399645 | Alkindi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2399646 | hydrocortisone 0.5 MG [Alkindi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399647 | hydrocortisone Oral Granules [Alkindi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399648 | Alkindi Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2399649 | Alkindi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2399650 | Alkindi Sprinkle 0.5 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399650 | Alkindi Sprinkle 0.5 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399650 | Alkindi Sprinkle 0.5 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399650 | Alkindi Sprinkle 0.5 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399651 | hydrocortisone 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2399652 | hydrocortisone 1 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399652 | hydrocortisone 1 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2399653 | hydrocortisone 1 MG [Alkindi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399654 | Alkindi Sprinkle 1 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399654 | Alkindi Sprinkle 1 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399654 | Alkindi Sprinkle 1 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399654 | Alkindi Sprinkle 1 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399655 | hydrocortisone 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2399656 | hydrocortisone 2 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399656 | hydrocortisone 2 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2399657 | hydrocortisone 2 MG [Alkindi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399658 | Alkindi Sprinkle 2 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399658 | Alkindi Sprinkle 2 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399658 | Alkindi Sprinkle 2 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399658 | Alkindi Sprinkle 2 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399659 | hydrocortisone 5 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399659 | hydrocortisone 5 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2399660 | hydrocortisone 5 MG [Alkindi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399661 | Alkindi Sprinkle 5 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399661 | Alkindi Sprinkle 5 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399661 | Alkindi Sprinkle 5 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399661 | Alkindi Sprinkle 5 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 239982 | cimetidine (as cimetidine hydrochloride) 150 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239982 | cimetidine (as cimetidine hydrochloride) 150 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239983 | azaTHIOprine 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239983 | azaTHIOprine 100 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 239983 | azaTHIOprine 100 MG Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 239983 | azaTHIOprine 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239983 | azaTHIOprine 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239983 | azaTHIOprine 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239983 | azaTHIOprine 100 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 239983 | azaTHIOprine 100 MG Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 239984 | muromonab-CD3 5 MG per 5 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239984 | muromonab-CD3 5 MG per 5 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399887 | Lyllana | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2399888 | estradiol 0.00104 MG/HR [Lyllana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399889 | estradiol Transdermal System [Lyllana] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399890 | Lyllana Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2399891 | Lyllana Transdermal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2399892 | Lyllana 0.025 MG/Day Twice Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399892 | Lyllana 0.025 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399892 | Lyllana 0.025 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399892 | Lyllana 0.025 MG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399893 | estradiol 0.00104 MG/HR Transdermal System [Lyllana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399893 | estradiol 0.00104 MG/HR Transdermal System [Lyllana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399894 | estradiol 0.00156 MG/HR [Lyllana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399895 | Lyllana 0.0375 MG/Day Twice Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399895 | Lyllana 0.0375 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399895 | Lyllana 0.0375 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399895 | Lyllana 0.0375 MG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399896 | estradiol 0.00156 MG/HR Transdermal System [Lyllana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399896 | estradiol 0.00156 MG/HR Transdermal System [Lyllana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399897 | estradiol 0.00208 MG/HR [Lyllana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399898 | Lyllana 0.05 MG/Day Twice Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399898 | Lyllana 0.05 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399898 | Lyllana 0.05 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399898 | Lyllana 0.05 MG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399899 | estradiol 0.00208 MG/HR Transdermal System [Lyllana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399899 | estradiol 0.00208 MG/HR Transdermal System [Lyllana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399899 | estradiol 0.00208 MG/HR Transdermal System [Lyllana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399900 | estradiol 0.00313 MG/HR [Lyllana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399901 | Lyllana 0.075 MG/Day Twice Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399901 | Lyllana 0.075 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399901 | Lyllana 0.075 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399901 | Lyllana 0.075 MG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399902 | estradiol 0.00313 MG/HR Transdermal System [Lyllana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399902 | estradiol 0.00313 MG/HR Transdermal System [Lyllana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399902 | estradiol 0.00313 MG/HR Transdermal System [Lyllana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399903 | estradiol 0.00417 MG/HR [Lyllana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399904 | Lyllana 0.1 MG/Day Twice Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399904 | Lyllana 0.1 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399904 | Lyllana 0.1 MG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399904 | Lyllana 0.1 MG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399905 | estradiol 0.00417 MG/HR Transdermal System [Lyllana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399905 | estradiol 0.00417 MG/HR Transdermal System [Lyllana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399905 | estradiol 0.00417 MG/HR Transdermal System [Lyllana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399906 | vasopressin (USP) 0.4 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2399907 | vasopressin (USP) 40 UNT in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2399907 | vasopressin (USP) 40 UNT in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399907 | vasopressin (USP) 40 UNT in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399908 | vasopressin (USP) 0.4 UNT/ML [Vasostrict] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399909 | Vasostrict 40 UNT in 100 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399909 | Vasostrict 40 UNT in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399909 | Vasostrict 40 UNT in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399909 | Vasostrict 40 UNT in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399910 | vasopressin (USP) 0.4 UNT/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2399910 | vasopressin (USP) 0.4 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2399911 | vasopressin (USP) 0.4 UNT/ML Injection [Vasostrict] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399911 | vasopressin (USP) 0.4 UNT/ML Injection [Vasostrict] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2399912 | vasopressin (USP) 0.6 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2399913 | vasopressin (USP) 60 UNT in 100 ML | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2399913 | vasopressin (USP) 60 UNT in 100 ML | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399913 | vasopressin (USP) 60 UNT in 100 ML | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399914 | vasopressin (USP) 0.6 UNT/ML [Vasostrict] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2399915 | Vasostrict 60 UNT in 100 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2399915 | Vasostrict 60 UNT in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399915 | Vasostrict 60 UNT in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2399915 | Vasostrict 60 UNT in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2399916 | vasopressin (USP) 0.6 UNT/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2399916 | vasopressin (USP) 0.6 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2399917 | vasopressin (USP) 0.6 UNT/ML Injection [Vasostrict] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2399917 | vasopressin (USP) 0.6 UNT/ML Injection [Vasostrict] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239994 | vitamin C 2000 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 239994 | vitamin C 2000 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239994 | vitamin C 2000 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 239998 | epoetin alfa 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239998 | epoetin alfa 2000 UNT in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239998 | epoetin alfa 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239998 | epoetin alfa 2000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239998 | epoetin alfa 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239999 | epoetin alfa 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239999 | epoetin alfa 4000 UNT in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 239999 | epoetin alfa 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 239999 | epoetin alfa 4000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 239999 | epoetin alfa 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |